Evidence map›Paper›PMID 40174960›Full record

ReviewEuropean respiratory review : an official journal of the European Respiratory Society2025

Advanced imaging techniques and artificial intelligence in pleural diseases: a narrative review.

Guido Marchi, Mattia Mercier, Jacopo Cefalo, Carmine Salerni, Martina Ferioli, Piero Candoli, Leonardo Gori, Federico Cucchiara, Giovanni Cenerini, Giacomo Guglielmi and 1 more

Abstract readReview
In one paragraph

Review in European respiratory review : an official journal of the European Respiratory Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Ultrasonic elastography-guided pleural biopsyThe European respiratory journal · 2025
    Trial
  3. Article
  4. Review
  5. Observational
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Pulmonary toxicity of immune checkpoint inhibitors.Breathe (Sheffield, England) · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Guido MarchiPulmonology Unit, Cardiothoracic and Vascular Department, University Hospital of Pisa, Pisa, Italy (guido.marchi@ao-pisa.toscana.it.ORCID https://orcid.org/0009-0000-6122-7792
Mattia MercierNeurology, Epilepsy and Movement Disorders Unit, Bambino Gesù Children's Hospital IRCCS, Full Member of European Reference Network on Rare and Complex Epilepsies EpiCARE, Rome, Italy.ORCID https://orcid.org/0000-0003-4239-8267
Jacopo CefaloRespiratory Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.ORCID https://orcid.org/0000-0003-4002-7374
Carmine SalerniRespiratory Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.ORCID https://orcid.org/0009-0003-8484-3661
Martina FerioliInterventional Pulmonology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.ORCID https://orcid.org/0000-0002-6429-6598
Piero CandoliInterventional Pulmonology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.ORCID https://orcid.org/0000-0003-0381-9313
Leonardo GoriPulmonology Unit, Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy.ORCID https://orcid.org/0000-0002-4211-7667
Federico CucchiaraDepartment of Surgical, Medical, Molecular and Critical Pathology, University of Pisa, Pisa, Italy.ORCID https://orcid.org/0000-0002-0946-750X
Giovanni CeneriniDepartment of Surgical, Medical, Molecular and Critical Pathology, University of Pisa, Pisa, Italy.ORCID https://orcid.org/0009-0004-2834-6043
Giacomo GuglielmiDepartment of Surgical, Medical, Molecular and Critical Pathology, University of Pisa, Pisa, Italy.
Michele MondoniRespiratory Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.ORCID https://orcid.org/0000-0001-9672-3534

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPleural diseases represent a significant healthcare burden, affecting over 350 000 patients annually in the US alone and requiring accurate diagnostic approaches for optimal management. Traditional imaging techniques have limitations in differentiating various pleural disorders and invasive procedures are usually required for definitive diagnosis.

methodsWe conducted a nonsystematic, narrative literature review aimed at describing the latest advances in imaging techniques and artificial intelligence (AI) applications in pleural diseases.

resultsNovel ultrasound-based techniques, such as elastography and contrast-enhanced ultrasound, are described for their promising diagnostic accuracy in differentiating malignant from benign pleural lesions. Quantitative imaging techniques utilising pixel-density measurements to noninvasively distinguish exudative from transudative effusions are highlighted. AI algorithms, which have shown remarkable performance in pleural abnormality detection, malignant effusion characterisation and automated pleural fluid volume quantification, are also described. Finally, the role of deep-learning models in early complication detection and automated analysis of follow-up imaging studies is examined.

conclusionsAdvanced imaging techniques and AI applications show promise in the management and follow-up of pleural diseases, improving diagnostic accuracy and reducing the need for invasive procedures. However, larger prospective studies are needed for validation. The integration of AI-driven imaging analysis with molecular and genomic data offers potential for personalised therapeutic strategies, although challenges in data privacy, algorithm transparency and clinical validation persist. This comprehensive approach may revolutionise pleural disease management, enhancing patient outcomes through more accurate, noninvasive diagnostic strategies.

Indexed as

Artificial IntelligenceImage Interpretation, Computer-AssistedPleural DiseasesHumansPredictive Value of TestsPrognosisReproducibility of Results

Identifiers

PMID40174960
PMCPMC11963007

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.